Paper11699197
CD38 expression correlates with adverse biological features and predicts poor clinical outcome in B-cell chronic lymphocytic leukemia.
D'Arena G and 7 others. Leuk Lymphoma, 2001. Cited by 68 papers, by iCite.
Cite this record
ConductScience Library. CD38 expression correlates with adverse biological features and predicts poor clinical outcome in B-cell chronic lymphocytic leukemia. Papers, record 11699197. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/11699197
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- CD38 expression correlates with adverse biological features and predicts poor clinical outcome in B-cell chronic lymphocytic leukemia.
- PubMed
Topics18
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Antigens, CD | Major topic |
| Antigens, Differentiation | Major topic |
| Antigens, Neoplasm | Major topic |
| Leukemia, Lymphocytic, Chronic, B-Cell | Major topic |
| NAD+ Nucleosidase | Major topic |
| ADP-ribosyl Cyclase | |
| ADP-ribosyl Cyclase 1 | |
| Adult | |
| Aged | |
| Biomarkers | |
| Cohort Studies | |
| Cytogenetic Analysis | |
| Humans | |
| Membrane Glycoproteins | |
| Middle Aged | |
| Prognosis | |
| Survival Analysis | |
| Treatment Outcome |
Source PubMed
Cited by26
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 68 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 39474602 | CD38 regulates chronic lymphocytic leukemia proliferation via CD45 phosphatase activity. | Mol Ther Oncol | 2024 | https://conductscience.org/library/papers/39474602 | PubMed |
| 38307031 | Inhibition of CD38 enzymatic activity enhances CAR-T cell immune-therapeutic efficacy by repressing glycolytic metabolism. | Cell Rep Med | 2024 | https://conductscience.org/library/papers/38307031 | PubMed |
| 33734005 | Intensity of antigen expression reflects IGHV mutational status and Dohner-defined prognostic categories in chronic lymphocytic leukemia, monoclonal B-cell lymphocytosis, and small lymphocytic lymphoma. | Leuk Lymphoma | 2021 | https://conductscience.org/library/papers/33734005 | PubMed |
| 32735048 | Prognostic models for newly-diagnosed chronic lymphocytic leukaemia in adults: a systematic review and meta-analysis. | Cochrane Database Syst Rev | 2020 | https://conductscience.org/library/papers/32735048 | PubMed |
| 32272636 | An Updated Perspective on Current Prognostic and Predictive Biomarkers in Chronic Lymphocytic Leukemia in the Context of Chemoimmunotherapy and Novel Targeted Therapy. | Cancers (Basel) | 2020 | https://conductscience.org/library/papers/32272636 | PubMed |
| 32158089 | Is Cd11c and Fmc7 Negativity in Chronic Lymphocytic Leukemia Poor Prognostic? | Indian J Hematol Blood Transfus | 2020 | https://conductscience.org/library/papers/32158089 | PubMed |
| 31914379 | The CD38/NAD/SIRTUIN1/EZH2 Axis Mitigates Cytotoxic CD8 T Cell Function and Identifies Patients with SLE Prone to Infections. | Cell Rep | 2020 | https://conductscience.org/library/papers/31914379 | PubMed |
| 30655861 | Increased serum levels of Galectin-9 in patients with chronic lymphocytic leukemia. | Oncol Lett | 2019 | https://conductscience.org/library/papers/30655861 | PubMed |
| 29748447 | Morphological, immunophenotypic, and genetic features of chronic lymphocytic leukemia with trisomy 12: a comprehensive review. | Haematologica | 2018 | https://conductscience.org/library/papers/29748447 | PubMed |
| 29473123 | Prognostic Factors in the Era of Targeted Therapies in CLL. | Curr Hematol Malig Rep | 2018 | https://conductscience.org/library/papers/29473123 | PubMed |
| 29234114 | Probing the requirement for CD38 in retinoic acid-induced HL-60 cell differentiation with a small molecule dimerizer and genetic knockout. | Sci Rep | 2017 | https://conductscience.org/library/papers/29234114 | PubMed |
| 25973046 | CD317 is over-expressed in B-cell chronic lymphocytic leukemia, but not B-cell acute lymphoblastic leukemia. | Int J Clin Exp Pathol | 2015 | https://conductscience.org/library/papers/25973046 | PubMed |
| 25800543 | Second cancers and Richter transformation are the leading causes of death in patients with trisomy 12 chronic lymphocytic leukemia. | Clin Lymphoma Myeloma Leuk | 2015 | https://conductscience.org/library/papers/25800543 | PubMed |
| 25332532 | Autoimmune haemolytic anaemia emerging during Campath treatment in a patient with CD5 negative chronic lymphocytic leukaemia. | Indian J Hematol Blood Transfus | 2014 | https://conductscience.org/library/papers/25332532 | PubMed |
| 24829201 | Trisomy 12 chronic lymphocytic leukemia cells exhibit upregulation of integrin signaling that is modulated by NOTCH1 mutations. | Blood | 2014 | https://conductscience.org/library/papers/24829201 | PubMed |
| 24660829 | Revealing CD38 cellular localization using a cell permeable, mechanism-based fluorescent small-molecule probe. | J Am Chem Soc | 2014 | https://conductscience.org/library/papers/24660829 | PubMed |
| 20956983 | Prognostic factors in chronic lymphocytic leukemia-what do we need to know? | Nat Rev Clin Oncol | 2011 | https://conductscience.org/library/papers/20956983 | PubMed |
| 20090781 | Serum metabolome analysis by 1H-NMR reveals differences between chronic lymphocytic leukaemia molecular subgroups. | Leukemia | 2010 | https://conductscience.org/library/papers/20090781 | PubMed |
| 19267204 | Immunohistochemical analysis of ZAP-70 expression in chronic lymphocytic leukemia. | J Mol Histol | 2009 | https://conductscience.org/library/papers/19267204 | PubMed |
| 18974118 | c-Cbl interacts with CD38 and promotes retinoic acid-induced differentiation and G0 arrest of human myeloblastic leukemia cells. | Cancer Res | 2008 | https://conductscience.org/library/papers/18974118 | PubMed |
Genes5
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| BST1 | 683 | PubTator's text mining | https://conductscience.org/library/genes/683 | NCBI Gene |
| CD19 | 930 | PubTator's text mining | https://conductscience.org/library/genes/930 | NCBI Gene |
| CD38 | 952 | PubTator's text mining | https://conductscience.org/library/genes/952 | NCBI Gene |
| CD5 | 921 | PubTator's text mining | https://conductscience.org/library/genes/921 | NCBI Gene |
| FCER2 | 2208 | PubTator's text mining | https://conductscience.org/library/genes/2208 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/11699197
GET https://conductscience.org/api/papers/v1/11699197/cited_by?page=2